 | • レポートコード：QYR9N7482 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、肺がんのグローバル市場について調査・分析したレポートで、種類別（SCLC肺がん、NSCLC肺がん）、用途別（病院と診療所、がん研究センター、実験室）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・肺がんの世界市場規模 ・主要企業別市場シェア ・肺がんの世界市場規模：種類別（SCLC肺がん、NSCLC肺がん） ・肺がんの世界市場規模：用途別（病院と診療所、がん研究センター、実験室） ・肺がんのアメリカ市場規模（種類別、用途別） ・肺がんのヨーロッパ市場規模（種類別、用途別） ・肺がんの中国市場規模（種類別、用途別） ・肺がんの日本市場規模（種類別、用途別） ・肺がんの東南アジア市場規模（種類別、用途別） ・肺がんのインド市場規模（種類別、用途別） ・肺がんの中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・肺がんの世界市場予測（2019年-2025年） ・肺がんの地域別市場予測（2019年-2025年） ... |
Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. This growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body. Most cancers that start in the lung, known as primary lung cancers, are carcinomas. The two main types are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). The most common symptoms are coughing (including coughing up blood), weight loss, shortness of breath, and chest pains.Lung cancer is the most common cause of cancer-related death in men and second most common in women after breast cancer. The most common age at diagnosis is 70 years. Overall, 17.4% of people in the United States diagnosed with lung cancer survive five years after the diagnosis, while outcomes on average are worse in the developing world.
In 2018, the global Lung Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Lung Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lung Cancer development in United States, Europe and China.
The key players covered in this study
Roche
Novartis
Pfizer
Merck
Bristol-Myers Squibb
Eli Lilly And Company
Sanof
…
Market segment by Type, the product can be split into
SCLC Lung Cancer
NSCLC Lung Cancer
Market segment by Application, split into
Hospital & Clinics
Cancer Research Centers
Laboratories
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Lung Cancer status, future forecast, growth opportunity, key market and key players.
To present the Lung Cancer development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Lung Cancer are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Lung Cancer Market Size Growth Rate by Type (2014-2025)
1.4.2 SCLC Lung Cancer
1.4.3 NSCLC Lung Cancer
1.5 Market by Application
1.5.1 Global Lung Cancer Market Share by Application (2014-2025)
1.5.2 Hospital & Clinics
1.5.3 Cancer Research Centers
1.5.4 Laboratories
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Lung Cancer Market Size
2.2 Lung Cancer Growth Trends by Regions
2.2.1 Lung Cancer Market Size by Regions (2014-2025)
2.2.2 Lung Cancer Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Lung Cancer Market Size by Manufacturers
3.1.1 Global Lung Cancer Revenue by Manufacturers (2014-2019)
3.1.2 Global Lung Cancer Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Lung Cancer Market Concentration Ratio (CR5 and HHI)
3.2 Lung Cancer Key Players Head office and Area Served
3.3 Key Players Lung Cancer Product/Solution/Service
3.4 Date of Enter into Lung Cancer Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Lung Cancer Market Size by Type (2014-2019)
4.2 Global Lung Cancer Market Size by Application (2014-2019)
5 United States
5.1 United States Lung Cancer Market Size (2014-2019)
5.2 Lung Cancer Key Players in United States
5.3 United States Lung Cancer Market Size by Type
5.4 United States Lung Cancer Market Size by Application
6 Europe
6.1 Europe Lung Cancer Market Size (2014-2019)
6.2 Lung Cancer Key Players in Europe
6.3 Europe Lung Cancer Market Size by Type
6.4 Europe Lung Cancer Market Size by Application
7 China
7.1 China Lung Cancer Market Size (2014-2019)
7.2 Lung Cancer Key Players in China
7.3 China Lung Cancer Market Size by Type
7.4 China Lung Cancer Market Size by Application
8 Japan
8.1 Japan Lung Cancer Market Size (2014-2019)
8.2 Lung Cancer Key Players in Japan
8.3 Japan Lung Cancer Market Size by Type
8.4 Japan Lung Cancer Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Lung Cancer Market Size (2014-2019)
9.2 Lung Cancer Key Players in Southeast Asia
9.3 Southeast Asia Lung Cancer Market Size by Type
9.4 Southeast Asia Lung Cancer Market Size by Application
10 India
10.1 India Lung Cancer Market Size (2014-2019)
10.2 Lung Cancer Key Players in India
10.3 India Lung Cancer Market Size by Type
10.4 India Lung Cancer Market Size by Application
11 Central & South America
11.1 Central & South America Lung Cancer Market Size (2014-2019)
11.2 Lung Cancer Key Players in Central & South America
11.3 Central & South America Lung Cancer Market Size by Type
11.4 Central & South America Lung Cancer Market Size by Application
12 International Players Profiles
12.1 Roche
12.1.1 Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Lung Cancer Introduction
12.1.4 Roche Revenue in Lung Cancer Business (2014-2019)
12.1.5 Roche Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Lung Cancer Introduction
12.2.4 Novartis Revenue in Lung Cancer Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Pfizer
12.3.1 Pfizer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Lung Cancer Introduction
12.3.4 Pfizer Revenue in Lung Cancer Business (2014-2019)
12.3.5 Pfizer Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Lung Cancer Introduction
12.4.4 Merck Revenue in Lung Cancer Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Bristol-Myers Squibb
12.5.1 Bristol-Myers Squibb Company Details
12.5.2 Company Description and Business Overview
12.5.3 Lung Cancer Introduction
12.5.4 Bristol-Myers Squibb Revenue in Lung Cancer Business (2014-2019)
12.5.5 Bristol-Myers Squibb Recent Development
12.6 Eli Lilly And Company
12.6.1 Eli Lilly And Company Company Details
12.6.2 Company Description and Business Overview
12.6.3 Lung Cancer Introduction
12.6.4 Eli Lilly And Company Revenue in Lung Cancer Business (2014-2019)
12.6.5 Eli Lilly And Company Recent Development
12.7 Sanof
12.7.1 Sanof Company Details
12.7.2 Company Description and Business Overview
12.7.3 Lung Cancer Introduction
12.7.4 Sanof Revenue in Lung Cancer Business (2014-2019)
12.7.5 Sanof Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Lung Cancer Key Market Segments
Table Key Players Lung Cancer Covered
Table Global Lung Cancer Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Lung Cancer Market Size Market Share by Type 2014-2025
Figure SCLC Lung Cancer Figures
Table Key Players of SCLC Lung Cancer
Figure NSCLC Lung Cancer Figures
Table Key Players of NSCLC Lung Cancer
Table Global Lung Cancer Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital & Clinics Case Studies
Figure Cancer Research Centers Case Studies
Figure Laboratories Case Studies
Figure Lung Cancer Report Years Considered
Table Global Lung Cancer Market Size 2014-2025 (Million US$)
Figure Global Lung Cancer Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Lung Cancer Market Size by Regions 2014-2025 (Million US$)
Table Global Lung Cancer Market Size by Regions 2014-2019 (Million US$)
Table Global Lung Cancer Market Share by Regions 2014-2019
Figure Global Lung Cancer Market Share by Regions 2014-2019
Figure Global Lung Cancer Market Share by Regions 2019
Table Market Top Trends
Table Global Lung Cancer Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Lung Cancer Market Share by Manufacturers (2014-2019)
Figure Global Lung Cancer Market Share by Manufacturers in 2018
Table Global Lung Cancer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Lung Cancer Product/Solution/Service
Table Date of Enter into Lung Cancer Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Lung Cancer Market Size by Type (2014-2019) (Million US$)
Table Global Lung Cancer Market Size Share by Type (2014-2019)
Figure Global Lung Cancer Market Size Market Share by Type (2014-2019)
Table Global Lung Cancer Market Size by Application (2014-2019) (Million US$)
Table Global Lung Cancer Market Size Share by Application (2014-2019)
Figure Global Lung Cancer Market Size Market Share by Application (2014-2019)
Figure Global Lung Cancer Revenue Market Share by Application in 2018
Figure United States Lung Cancer Market Size 2014-2019 (Million US$)
Table United States Key Players Lung Cancer Revenue (2018-2019) (Million US$)
Table United States Key Players Lung Cancer Market Share (2018-2019)
Table United States Lung Cancer Market Size by Type (2014-2019) (Million US$)
Table United States Lung Cancer Market Share by Type (2014-2019)
Table United States Lung Cancer Market Size by Application (2014-2019) (Million US$)
Table United States Lung Cancer Market Share by Application (2014-2019)
Figure Europe Lung Cancer Market Size 2014-2019 (Million US$)
Table Europe Key Players Lung Cancer Revenue (2018-2019) (Million US$)
Table Europe Key Players Lung Cancer Market Share (2018-2019)
Table Europe Lung Cancer Market Size by Type (2014-2019) (Million US$)
Table Europe Lung Cancer Market Share by Type (2014-2019)
Table Europe Lung Cancer Market Size by Application (2014-2019) (Million US$)
Table Europe Lung Cancer Market Share by Application (2014-2019)
Figure China Lung Cancer Market Size 2014-2019 (Million US$)
Table China Key Players Lung Cancer Revenue (2018-2019) (Million US$)
Table China Key Players Lung Cancer Market Share (2018-2019)
Table China Lung Cancer Market Size by Type (2014-20189) (Million US$)
Table China Lung Cancer Market Share by Type (2014-2019)
Table China Lung Cancer Market Size by Application (2014-2019) (Million US$)
Table China Lung Cancer Market Share by Application (2014-2019)
Figure Japan Lung Cancer Market Size 2014-2019 (Million US$)
Table Japan Key Players Lung Cancer Revenue (2018-2019) (Million US$)
Table Japan Key Players Lung Cancer Market Share (2018-2019)
Table Japan Lung Cancer Market Size by Type (2014-2019) (Million US$)
Table Japan Lung Cancer Market Share by Type (2014-2019)
Table Japan Lung Cancer Market Size by Application (2014-2019) (Million US$)
Table Japan Lung Cancer Market Share by Application (2014-2019)
Figure Southeast Asia Lung Cancer Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Lung Cancer Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Lung Cancer Market Share (2018-2019)
Table Southeast Asia Lung Cancer Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Lung Cancer Market Share by Type (2014-2019)
Table Southeast Asia Lung Cancer Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Lung Cancer Market Share by Application (2014-2019)
Figure India Lung Cancer Market Size 2014-2019 (Million US$)
Table India Key Players Lung Cancer Revenue (2018-2019) (Million US$)
Table India Key Players Lung Cancer Market Share (2018-2019)
Table India Lung Cancer Market Size by Type (2014-2019) (Million US$)
Table India Lung Cancer Market Share by Type (2014-2019)
Table India Lung Cancer Market Size by Application (2014-2019) (Million US$)
Table India Lung Cancer Market Share by Application (2014-2019)
Figure Central & South America Lung Cancer Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Lung Cancer Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Lung Cancer Market Share (2018-2019)
Table Central & South America Lung Cancer Market Size by Type (2014-2019) (Million US$)
Table Central & South America Lung Cancer Market Share by Type (2014-2019)
Table Central & South America Lung Cancer Market Size by Application (2014-2019) (Million US$)
Table Central & South America Lung Cancer Market Share by Application (2014-2019)
Table Roche Company Details
Table Roche Revenue in Lung Cancer Business (2014-2019) (Million US$)
Figure Roche Revenue Growth Rate in Lung Cancer Business (2014-2019)
Table Roche Recent Development
Table Novartis Company Details
Table Novartis Revenue in Lung Cancer Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Lung Cancer Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Lung Cancer Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Lung Cancer Business (2014-2019)
Table Pfizer Recent Development
Table Merck Company Details
Table Merck Revenue in Lung Cancer Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Lung Cancer Business (2014-2019)
Table Merck Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Lung Cancer Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Lung Cancer Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Eli Lilly And Company Company Details
Table Eli Lilly And Company Revenue in Lung Cancer Business (2014-2019)(Million US$)
Figure Eli Lilly And Company Revenue Growth Rate in Lung Cancer Business (2014-2019)
Table Eli Lilly And Company Recent Development
Table Sanof Company Details
Table Sanof Revenue in Lung Cancer Business (2014-2019)(Million US$)
Figure Sanof Revenue Growth Rate in Lung Cancer Business (2014-2019)
Table Sanof Recent Development
Table Global Lung Cancer Market Size by Regions (Million US$) 2019-2025
Figure Global Lung Cancer Market Size Share by Regions (2019-2025)
Figure Global Lung Cancer Market Size Share by Regions in 2025
Figure United States Lung Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Europe Lung Cancer Market Size Forecast (2019-2025)(Million USD)
Figure China Lung Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Japan Lung Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Lung Cancer Market Size Forecast (2019-2025)(Million USD)
Figure India Lung Cancer Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Lung Cancer Market Size Forecast (2019-2025)(Million USD)
Table Global Lung Cancer Market Size by Product (2019-2025) (Million US$)
Figure Global Lung Cancer Market Size by Product (2019-2025)
Figure Global Lung Cancer Market Size by Product in 2025
Table Global Lung Cancer Market Size by Application (2019-2025) (Million US$)
Figure Global Lung Cancer Market Size by Application (2019-2025)
Figure Global Lung Cancer Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の肺がんの診断と治療市場：市場規模・現状・予測 Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung.Robust healthcare expenditure within the developed countries, increasing pollution, government initiatives for lung cancer, and rising cases of smoking are some of the major factors that fuel the g…- 世界の肺がん液体バイオプ市場：市場規模・現状・予測 In 2018, the global Lung Cancer Liquid Biops market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Lung Cancer Liquid Biops status, future forecast, growth opportunity, key market and key players. Th…
- 世界の肺がんの診断市場：市場規模・現状・予測 Diagnosis of lung cancer depends on lung histology or sputum shedding cytology. Screening methods for lung cancer mainly include X-ray chest X-ray and sputum cytology, low-dose spiral CT, blood and sputum biomarkers, and exhalation gas monitoring.As people's awareness of cancer increases and technol…
- 世界の非侵襲がん診断市場：市場規模・現状・予測 In 2018, the global Non-invasive Cancer Diagnosis market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Non-invasive Cancer Diagnosis status, future forecast, growth opportunity, key market and key p…
- 世界のがん治療薬のパーソナライズ市場：市場規模・現状・予測 Global cancer drugs market is primarily driven by growing incidences of target disease such as lung cancer, breast cancer, cervical cancer, etc. across the globe. Other major driving factors are increasing research and development on biological and targeted drug therapies for the treatment of cancer…